Clinical Trials for Rallybio

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Rallybio

Clinical Trials (3)

NCT06797375
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants
PHASE1Recruiting
16 participants
Started: Apr 14, 2025 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06435845
Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization
PHASE2Active, not recruiting
8 participants
Started: Nov 21, 2024 · Completed: May 31, 2027
1 condition1 sponsor3 locations
NCT05345561
Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
N/AActive, not recruiting
30,000 participants
Started: Mar 14, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor28 locations